Skip to main content
SpringerLink
Log in

Design, synthesis and QSAR study of arylidene indoles as anti-platelet aggregation inhibitors

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A series of novel substituted indole carbohydrazide was synthesized and evaluated for anti-platelet aggregation activity. The structures of the synthesized compounds were confirmed by spectral data and elemental analysis and were evaluated for their ability to inhibit platelet aggregation induced by adenosine diphosphate, arachidonic acid (AA) and collagen. Compounds 3e and 3b exhibited the highest activities against the platelet aggregation induced by collagen with IC50 values of 12.7 and 13.3 µM, respectively, and 2h with IC50 value of 51.88 µM and 2i with IC50 of 44.38 µM efficiently inhibited platelet aggregation induced by AA. The QSAR investigation indicated the importance of the topological, constitutional and geometrical parameters (PW3, PW4, LP1 and GATS6v) in describing the anti-platelet aggregation activity of the synthesized hydrazides. Evaluation of cytotoxic activity of the compounds against L929 cell line and three cancer cell lines revealed that none of the compounds have significant cytotoxicity.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Scheme 1
Fig. 3

Similar content being viewed by others

References

  • Aggarwal N, Kumar R, Dureja P, Khurana JM (2011) Synthesis, antimicrobial evaluation and QSAR analysis of novel nalidixic acid based 1,2,4-triazole derivatives. Eur J Med Chem 46:4089–4099

    Article  PubMed  CAS  Google Scholar 

  • Alemany A, Bernabé M, Elorriaga C, Fernández AE, Lora-Tamayo M, Nieto O (1966) Potential psychotropic agents. I. Synthesis of 1-(2-indolylcarbonyl)-2-alkylhydrazines, 1-(3-indolylcarbonyl)-2-alkylhydrazines and 1-(3-indolylacetyl)-2-alkylhydrazines, and measurement, in vitro, of their monoamine oxidase inhibitory activity. Bull Soc Chim Fr 8:2486–2497

    PubMed  CAS  Google Scholar 

  • Bao XP, Zheng PC, Liu Y, Tan Z, Zhou YH, Song BA (2013) Salicylaldehyde-indole-2-acylhydrazone: a simple, colorimetric and absorption ratiometric chemosensor for acetate ion. Supramol Chem 25:246–253

    Article  CAS  Google Scholar 

  • Bezerra-Neto HJC, Lacerda DI, Miranda ALP, Alves HM, Barreiro EJ, Fraga CAM (2006) Design and synthesis of 3,4-methylenedioxy-6-nitrophenoxyacetylhydrazone derivatives obtained from natural safrole: new lead-agents with analgesic and antipyretic properties. Bioorg Med Chem 14:7924–7935

    Article  CAS  Google Scholar 

  • Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929

    Article  PubMed  CAS  Google Scholar 

  • Brito FCF, Kummerle AE, Lugnier C, Fraga CAM, Barreiro EJ, Miranda ALP (2010) Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition. Eur J Pharmacol 638:5–12

    Article  PubMed  CAS  Google Scholar 

  • Cunha AC, Figueiredo JM, Tributino JLM, Miranda ALP, Castro HC, Zingali RB, Fraga CAM, de Souza MCBV, Ferreira VF, Barreiro EJ (2003) Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives. Bioorg Med Chem 11:2051–2059

    Article  PubMed  CAS  Google Scholar 

  • DeCandia M, Liantonio F, Carotti A, De Cristofaro R, Altomare C (2009) Fluorinated benzyloxyphenyl piperidine-4-carboxamides with dual function against thrombosis: inhibitors of factor Xa and platelet aggregation. J Med Chem 52:1018–1028

    Article  CAS  Google Scholar 

  • Du H, Hu Z, Bazzoli A, Zhang Y (2011) Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method. PLoS ONE 6:e22367

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Duarte CD, Tributino JLM, Lacerda DI, Martins MV, Alexandre-Moreira MS, Dutra F, Bechara EJH, De-Paula FS, Goulart MOF, Ferreira J, Calixto JB, Nunes MP, Bertho AL, Miranda ALP, Barreiro EJ, Fraga CAM (2007) Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg Med Chem 15:2421–2433

    Article  PubMed  CAS  Google Scholar 

  • Firoozpour L, Edraki N, Nakhjiri M, Emami S, Safavi M, Ardestani SK, Khoshneviszadeh M, Shafiee A, Foroumadi A (2012) Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Arch Pharm Res 35:2117–2125

    Article  PubMed  CAS  Google Scholar 

  • Haj Mohammad Ebrahim Tehrani K, Sardari S, Mashayekhi V, Esfahani Zadeh M, Azerang M, Kobarfard F (2013) One pot synthesis and biological activity evaluation of novel Schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole. Chem Pharm Bull 61:160–166

    Article  PubMed  Google Scholar 

  • Kumar M, Narasimhan B, Kumar P, Ramasamy K, Mani V, Kumar Mishra R, Abdul Majeed AB (2014) 4-(1-Aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides: synthesis, antimicrobial, anticancer evaluation and QSAR studies. Arab J Chem 7:436–447

    Article  CAS  Google Scholar 

  • Lather V, Madan AK (2005) Topological models for the prediction of anti-HIV activity of dihydro (alkylthio) (naphthylmethyl) oxopyrimidines. Bioorg Med Chem 13:1599–1604

    Article  PubMed  CAS  Google Scholar 

  • Mashayekhi V, Hajmohammad Ebrahim Tehrani K, Amidi S, Kobarfard F (2013a) Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity. Chem Pharm Bull 61:144–150

    Article  PubMed  CAS  Google Scholar 

  • Mashayekhi V, Hajmohammad Ebrahim Tehrani K, Azerang P, Sardari S, Kobarfard F (2013b) Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones. Arch Pharm Res 36:9

    Google Scholar 

  • Mirfazli SS, Kobarfard F, Firoozpour L, Asadipour A, Esfahanizadeh M, Tabib M, Shafiee A, Foroumadi A (2014) N-Substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity. DARU J Pharm Sci 22:65

    Article  CAS  Google Scholar 

  • Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zadeh M, Ardestani SK, Khoshneviszadeh M, Foroumadi A, Shafiee A (2012) Asymmetrical 2,6-bis(benzylidene)cyclohexanones: synthesis, cytotoxic activity and QSAR study. Eur J Med Chem 50:113–123

    Article  PubMed  CAS  Google Scholar 

  • Nazare M, Will M, Essrich DW, Matter H, Ritter K, Urmann M, Bauer A, Schreuder H, Dudda A, Czech J, Lorenz M, Laux V, Wehner V (2004) Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents. Bioorg Med Chem Lett 14:4191–4195

    Article  PubMed  CAS  Google Scholar 

  • Palla G, Predieri G, Domiano P, Vignali C, Turner W (1986) Conformational behavior and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron 42:3649–3654

    Article  CAS  Google Scholar 

  • Park MK, Rhee YH, Lee HJ, Lee EO, Kim KH, Park MJ, Jeon BH, Shim BS, Jung CH, Choi SH, Ahn KS, Kim SH (2008) Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo. Phytother Res 22:58–64

    Article  PubMed  CAS  Google Scholar 

  • Puzyn T, Cronin MTD, Leszczynski J (2010) Recent advances in QSAR studies. Springer, London

    Book  Google Scholar 

  • Rathod AK, Khatri NC, Kulkurni GB (2012) Synthesis and QSAR studies on 4,5-diphenylimydazolylpyrimidine-5-carboxylate (DPIP) against antifungal activity. Int J Sci Res Publ 2:1–6

    Google Scholar 

  • Reddy MV, Shen YC, Yang JS, Hwang TL, Bastow KF, Qian K, Lee KH, Wu TS (2011) New bichalcone analogs as NF-kB inhibitors and as cytotoxic agents inducing Fas/CD95-dependent apoptosis. Bioorg Med Chem 19:1895–1906

    Article  PubMed  CAS  Google Scholar 

  • Silva GA, Costa LMM, Brito FCF, Miranda ALP, Barreiro EJ, Fraga CAM (2004) New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Bioorg Med Chem 12:3149–3158

    Article  PubMed  CAS  Google Scholar 

  • Singh S, Mandal PK, Singh N, Misra AK, Singh S, Chaturvedi V, Saxena AK (2010) Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR). Bioorg Med Chem Lett 20:2597–2600

    Article  PubMed  CAS  Google Scholar 

  • Siwek A, Stączek P, Stefańska J (2011) Synthesis and structure activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity: search for molecular basis of antibacterial activity of thiosemicarbazides. Eur J Med Chem 46:5717–5726

    Article  PubMed  CAS  Google Scholar 

  • Syakaev V, Podyachev S, Buzykin B, Latypov S, Habicher W, Konovalov A (2006) NMR study of conformation and isomerization of aryl- and heteroarylaldehyde 4-tert-butylphenoxyacetylhydrazones. J Mol Struct 788:55–62

    Article  CAS  Google Scholar 

  • Todeschini R, Consonni V (2000) Handbook of molecular descriptors. Wiley-VCH, Weinheim

    Book  Google Scholar 

  • Unsal-Tan O, Ozden K, Rauk A, Balkan A (2010) Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones. Eur J Med Chem 45:2345–2352

    Article  PubMed  CAS  Google Scholar 

  • Vahdani S, Bayat Z (2011) Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method. J Chem Pharm Res 3:565–575

    CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledged the financial support from Research Council of Tehran University of Medical Sciences.

Author information

Authors and Affiliations

  1. Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Seyedeh Sara Mirfazli, Mohammad Jeiroudi, Alireza Foroumadi & Abbas Shafiee

  2. Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Mehdi Khoshneviszadeh

  3. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Farzad Kobarfard

  4. Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Vali Asr Ave. Niayesh Junction, P.O. Box 14155-6153, Tehran, Iran

    Farzad Kobarfard

Authors
  1. Seyedeh Sara Mirfazli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehdi Khoshneviszadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Jeiroudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alireza Foroumadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Farzad Kobarfard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abbas Shafiee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Farzad Kobarfard or Abbas Shafiee.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mirfazli, S.S., Khoshneviszadeh, M., Jeiroudi, M. et al. Design, synthesis and QSAR study of arylidene indoles as anti-platelet aggregation inhibitors. Med Chem Res 25, 1–18 (2016). https://doi.org/10.1007/s00044-015-1440-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-015-1440-7

Keywords

Search

Navigation